NCT04149860View on ClinicalTrials.gov

Study With Lu AF87908 in Healthy Participants and Participants With Alzheimer's Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

September 27, 2019

Primary Completion Date

July 19, 2023

Study Completion Date

July 19, 2023

Conditions
HealthyAlzheimer Disease
Interventions
DRUG

Lu AF87908

Lu AF87908 concentrate for solution for intravenous (IV) infusion

DRUG

Placebo

Concentrate for solution for IV infusion

Trial Locations (6)

10019

Clinilabs, Inc., New York

30030

iResearch Atlanta LLC, Decatur

33014

Panax Clinical Research, Miami

33024

Research Center of America, Hollywood

91206

PAREXEL International, Glendale

08540

Princeton Medical Institute, Princeton

All Listed Sponsors
lead

H. Lundbeck A/S

INDUSTRY

NCT04149860 - Study With Lu AF87908 in Healthy Participants and Participants With Alzheimer's Disease | Biotech Hunter | Biotech Hunter